AtriCure - Stock Price History | ATRC
Historical daily share price chart and data for AtriCure since 2019 adjusted for splits. The latest closing stock price for AtriCure as of December 13, 2019 is 30.49.
- The all-time high AtriCure stock closing price was 35.58 on September 20, 2018.
- The AtriCure 52-week high stock price is 33.92, which is 11.2% above the current share price.
- The AtriCure 52-week low stock price is 22.57, which is 26% below the current share price.
- The average AtriCure stock price for the last 52 weeks is 29.00.
| AtriCure Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2018 | 26.1470 | 18.4700 | 35.5800 | 15.0500 | 30.6000 | 67.76% |
| 2017 | 20.3076 | 19.2000 | 24.8800 | 14.9400 | 18.2400 | -6.80% |
| 2016 | 16.5649 | 21.1600 | 21.4700 | 13.5400 | 19.5700 | -12.79% |
| 2015 | 21.8535 | 19.7800 | 27.9300 | 17.4000 | 22.4400 | 12.42% |
| 2014 | 17.5247 | 18.0300 | 22.1800 | 13.6400 | 19.9600 | 6.85% |
| 2013 | 10.3316 | 7.1400 | 18.9300 | 7.1400 | 18.6800 | 170.72% |
| 2012 | 8.5684 | 11.7400 | 11.9600 | 5.9100 | 6.9000 | -37.84% |
| 2011 | 11.4511 | 10.2500 | 14.5000 | 8.5400 | 11.1000 | 8.08% |
| 2010 | 6.7755 | 5.6500 | 10.2700 | 4.5600 | 10.2700 | 70.03% |
| 2009 | 3.2447 | 2.2000 | 6.0500 | 1.0700 | 6.0400 | 172.07% |
| 2008 | 9.7793 | 13.2400 | 14.0500 | 2.0000 | 2.2200 | -83.07% |
| 2007 | 10.6159 | 9.1500 | 13.5900 | 8.4400 | 13.1100 | 46.64% |
| 2006 | 8.1361 | 10.7900 | 11.8000 | 5.4400 | 8.9400 | -16.06% |
| 2005 | 13.1674 | 14.0800 | 14.9500 | 10.6500 | 10.6500 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.206B | $0.202B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $152.706B | 27.85 |
| Medtronic (MDT) | Ireland | $152.160B | 21.02 |
| Stryker (SYK) | United States | $75.917B | 25.53 |
| Boston Scientific (BSX) | United States | $62.848B | 29.66 |
| Baxter (BAX) | United States | $42.866B | 25.99 |
| Essilor Luxottica (ESLOY) | France | $34.245B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.456B | 19.11 |
| Terumo (TRUMY) | Japan | $27.092B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.394B | 0.00 |
| Coloplast (CLPBY) | Denmark | $24.797B | 38.27 |
| ResMed (RMD) | United States | $22.090B | 40.75 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.228B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $19.217B | 0.00 |
| Insulet (PODD) | United States | $10.859B | 516.62 |
| Bio-Rad Laboratories (BIO) | United States | $10.615B | 50.95 |
| William Demant Holdings (WILYY) | Denmark | $7.675B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.616B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.340B | 13.69 |
| Hill-Rom Holdings (HRC) | United States | $7.289B | 21.49 |
| Canopy Growth (CGC) | Canada | $7.208B | 0.00 |
| Haemonetics (HAE) | United States | $5.904B | 39.89 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.472B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 0.00 |
| NuVasive (NUVA) | United States | $3.947B | 31.08 |
| ICU Medical (ICUI) | United States | $3.686B | 24.03 |
| Neogen (NEOG) | United States | $3.583B | 59.96 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.293B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.073B | 0.00 |
| Quidel (QDEL) | United States | $2.950B | 27.99 |
| Aurora Cannabis (ACB) | Canada | $2.865B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.750B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.495B | 56.30 |
| Cardiovascular Systems (CSII) | United States | $1.607B | 0.00 |
| Aphria (APHA) | $1.384B | 0.00 | |
| InMode (INMD) | Israel | $1.242B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.199B | 24.01 |
| TG Therapeutics (TGTX) | United States | $1.006B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.969B | 18.14 |
| NanoString Technologies (NSTG) | United States | $0.912B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.820B | 31.41 |
| Lantheus Holdings (LNTH) | United States | $0.795B | 19.86 |
| LeMaitre Vascular (LMAT) | United States | $0.711B | 39.98 |
| PetIQ (PETQ) | United States | $0.695B | 16.96 |
| Quanterix (QTRX) | United States | $0.676B | 0.00 |
| Omeros (OMER) | United States | $0.667B | 0.00 |
| HEXO (HEXO) | $0.576B | 0.00 | |
| Cerus (CERS) | United States | $0.560B | 0.00 |
| Surmodics (SRDX) | United States | $0.552B | 57.38 |
| MacroGenics (MGNX) | United States | $0.518B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.497B | 29.80 |
| Meridian Bioscience (VIVO) | United States | $0.413B | 14.21 |
| Organigram Holdings (OGI) | Canada | $0.405B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.396B | 28.68 |
| Owens & Minor (OMI) | United States | $0.346B | 12.81 |
| BioLife Solutions (BLFS) | United States | $0.320B | 130.58 |
| Zynex (ZYXI) | United States | $0.305B | 34.48 |
| Bovie Medical (APYX) | United States | $0.276B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.274B | 0.00 |
| United Health Products (UEEC) | United States | $0.251B | 0.00 |
| Vapotherm (VAPO) | United States | $0.244B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.238B | 25.08 |
| Repro-Med Systems (KRMD) | United States | $0.228B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.172B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.171B | 0.00 |
| Female Health (VERU) | United States | $0.157B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.142B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.130B | 9.18 |
| MTech Acquisition (KERN) | United States | $0.128B | 0.00 |
| Chimerix (CMRX) | United States | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 22.93 |
| Chembio Diagnostics (CEMI) | United States | $0.078B | 0.00 |
| Nephros (NEPH) | United States | $0.066B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.062B | 0.00 |
| Surface Oncology (SURF) | United States | $0.049B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.014B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
